Articles in Scholarly Journals [Incomplete List]

1. Therapeutic Potential of Retinoid X Receptor Modulators for the Treatment of the Metabolic Syndrome
   PPAR Research, vol. 2007, Article ID 94156, 12 pages, 2007
2. Investigational PPAR-gamma agonists for the treatment of Type 2 diabetes
   Expert Opinion on Investigational Drugs, vol. 15, no. 7, pp. 763–778, 2006
3. Synthesis and evaluation of aminomethyl dihydrocinnamates as a new class of PPAR ligands
   Bioorganic & Medicinal Chemistry Letters, vol. 16, no. 24, pp. 6328–6333, 2006
4. Molecular determinants of FGF-21 activity—synergy and cross-talk with PPAR? signaling
   Journal of Cellular Physiology, vol. 210, no. 1, pp. 1–6, 2006
5. Today's challenges and tomorrow's opportunities: ligands to peroxisome proliferator-activated receptors as therapies for type 2 diabetes and the metabolic syndrome
   Drug Development Research, vol. 67, no. 7, pp. 574–578, 2006
6. Deficiency of Adiponectin Receptor 2 Reduces Diet-Induced Insulin Resistance but Promotes Type 2 Diabetes
   Endocrinology, vol. 148, no. 2, pp. 683–692, 2006
7. A Peroxisome Proliferator-Activated Receptor �/� Dual Agonist with a Unique in Vitro Profile and Potent Glucose and Lipid Effects in Rodent Models of Type 2 Diabetes and Dyslipidemia
   Molecular Endocrinology, vol. 19, no. 6, pp. 1593–1605, 2005
8. 2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituents
   Bioorganic & Medicinal Chemistry Letters, vol. 15, no. 1, pp. 51–55, 2005
9. Biological Characterization of a Heterodimer-Selective Retinoid X Receptor Modulator: Potential Benefits for the Treatment of Type 2 Diabetes
   Endocrinology, vol. 147, no. 2, pp. 1044–1053, 2005
10. Editorial
    Drug Discovery Today: Therapeutic Strategies, vol. 2, no. 2, pp. iii–v, 2005
11. Ligands to peroxisome proliferator-activated receptors as therapeutic options for metabolic syndrome
    Drug Discovery Today: Therapeutic Strategies, vol. 2, no. 2, pp. 165–169, 2005
12. Design and synthesis of benzofused heterocyclic RXR modulators
    Bioorganic & Medicinal Chemistry Letters, vol. 14, no. 11, pp. 2759–2763, 2004
13. Design, synthesis and structure–activity relationship of novel RXR-selective modulators
    Bioorganic & Medicinal Chemistry Letters, vol. 14, no. 6, pp. 1593–1598, 2004
14. Rosiglitazone Induction of Insig-1 in White Adipose Tissue Reveals a Novel Interplay of Peroxisome Proliferator-activated Receptor   and Sterol Regulatory Element-binding Protein in the Regulation of Adipogenesis
    Journal of Biological Chemistry, vol. 279, no. 23, pp. 23908–23915, 2004
15. Design and synthesis of novel RXR-selective modulators with improved pharmacological profile
    Bioorganic & Medicinal Chemistry Letters, vol. 13, no. 22, pp. 4071–4075, 2003
16. Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis
    Journal of Biological Chemistry, vol. 278, no. 2, pp. 1131–1136, 2003
17. Journal of Medicinal Chemistry, vol. 46, no. 19, pp. 4087–4103, 2003
18. Journal of Medicinal Chemistry, vol. 46, no. 13, pp. 2683–2696, 2003
19. Design and synthesis of fluorinated RXR modulators
    Bioorganic & Medicinal Chemistry Letters, vol. 13, no. 19, pp. 3191–3195, 2003
20. Possible relationship between changes in islet neogenesis and islet neogenesis-associated protein-positive cell mass induced by sucrose administration to normal hamsters
    Journal of Endocrinology, vol. 165, no. 3, pp. 725–733, 2000
21. In Vivo Adenoviral Delivery of Recombinant Human Protein Kinase C-zeta Stimulates Glucose Transport Activity in Rat Skeletal Muscle
    Journal of Biological Chemistry, vol. 274, no. 32, pp. 22139–22142, 1999
22. Stimulation of pancreatic ß-cell proliferation by growth hormone is glucose-dependent: signal transduction via Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling
    Biochemical Journal, vol. 344, no. 3, p. 649, 1999
23. Protein Kinase C Isozymes Differentially Regulate Promoters Containing PEA-3/12-O-Tetradecanoylphorbol-13-acetate Response Element Motifs
    Journal of Biological Chemistry, vol. 271, no. 35, pp. 21666–21671, 1996
24. Detection of an IE responsive element(s) in the BamHI J fragment of human cytomegalovirus AD169
    Virology, vol. 177, no. 2, pp. 496–504, 1990
25. Effect of fluorine containing compounds on the activity of glycolytic enzymes in rat hepatocytes
    Biochemical and Biophysical Research Communications, vol. 94, no. 3, pp. 901–908, 1980
26. Influence of NaF and Na2PO3F(MFP) on glucose metabolism in rat hepatocytes*1
    Biochemical and Biophysical Research Communications, vol. 91, no. 2, pp. 583–591, 1979